Guest Post: Open Source in TN Govt

/ By / Copyright, Privacy

Kartik Chawla, a 2nd year student from Nalsar University of Law, brings our attention to a recent development wherein the Tamil Nadu State Government is considering installing a home-grown Open Source Operating System as one of the mandatory OSes in the various govt departments. In this post, Kartik notes that while a focus the affordability of Open Source softwares is evident, the government must also tread carefully with respect to possible security concerns. Open Source in TN Govt In a letter dated […]

Guest Post: Open Source in TN Govt Read More »

EU draft legislation on clinical drugs trials

/ By / Drug Regulation

European Union is expected to finalise and give formal approval to the draft legislation on clinical drugs trials on 02 April 2014. The draft legislation inter alia requires all trial data to be placed in an accessible database. It also specifies that study protocols and full clinical study reports should be made public after approval. As members deliberate on the legislation, European Court of Justice (“ECJ“) will emerge as the legal battle field between drug companies and European Medicines Agency (“EMA“), the

EU draft legislation on clinical drugs trials Read More »

SpicyIP Events: Colloquium on Selected IP Issues, NLU-D

/ By / Event

NLU Delhi brings us news of an exciting event happening at their campus tomorrow evening – a panel discussion on “Early Market Entry of Biosimilars in India: Implications of the Roche/Mylan Dispute”. Please see the invite attached below: Colloquium on Selected IP Issues The NLU Delhi Colloquium on Selected Intellectual Property Issues is a panel/ speakers’ series launched with an aim to generate a nuanced dialogue and to promote free-thinking on emergent issues in IP law, policy and theory. The current

SpicyIP Events: Colloquium on Selected IP Issues, NLU-D Read More »

AIDS Activists stage protest against Big Pharma at the Economist’s Pharma Summit 2014

/ By / Drug Regulation, Patent

The recently concluded Economist Events’ 20th Annual Pharma Summit held in London was witness to picketing and protests by AIDS activists demanding an end to Big Pharma’s interference in South African Patent law reforms. The theme of this year’s summit was ‘Reinventing Business Models and Markets’, which observed the challenges the pharmaceutical industry faced in the current climate and the future of life science innovation. Expectedly, the event was high profile and attended by Companies like MSD, Pfizer, Sanofi Aventis

AIDS Activists stage protest against Big Pharma at the Economist’s Pharma Summit 2014 Read More »

Guest Post: On the Need for Network Neutrality

/ By / Competition Law, Innovation, Others

Aside from a post (see here) that Prashant had written on it, network neutrality is a topic we’ve not often touched upon in this blog. In light of this, we are very glad to bring our readers a guest post on some recent developments in the network neutrality debate, by Kartik Chawla, an enterprising 2nd year at Nalsar University of Law. Network Neutrality The debate around Network Neutrality is a decades old debate, but it is not any less relevant for

Guest Post: On the Need for Network Neutrality Read More »

Guest Post: Heightened Pleading Standards for US Patent Cases?

/ By / Patent

We’re happy to bring our readers a post from a friend of the blog and one of our regular guest bloggers, Chris Ohly, a leading patent litigator in the US. This post concerns a recent US case that imposes heightened standards for pleading in complaints in patent cases. For those interested, Chris has also made available a more detailed version of this post along with related case materials here. As he states there, “Heightened pleading requirements will alter the course

Guest Post: Heightened Pleading Standards for US Patent Cases? Read More »

Taking IP on a spin – round 2

/ By / Innovation, Patent

This is the second post of a two part series where I am looking into the manner in which certain industry lobbies have worked towards creating a certain perception/narrative of IP in which maximalist IP policies are hailed as the best and only way forward. In part 1, I discussed the heavy industry influence in the creation of the TRIPS agreement as well as the intellectually dishonest methods in which IP maximalist policies were justified. Continuing from where I left

Taking IP on a spin – round 2 Read More »

Spicyip Tidbit: The 2015 Rankings for Programs in IP and Tech Law in the US are Out!

/ By / Others

As LLM admission responses start to roll out, Hal Wegner brings our attention to something IP focused LLM applicants may be interested in. The 2015 U.S. News rankings for IP programs in U.S. universities are out and there are some big moves on the ranking table – both up and down. Stanford University’s IP program moves to the top of the list while Berkley drops down to second. The significant movers are DePaul, Fordham, Suffolk, Penn and UCLA, each university

Spicyip Tidbit: The 2015 Rankings for Programs in IP and Tech Law in the US are Out! Read More »

Of Deceptive Similarity, Vacating of Injunctions and Country Liquor

/ By / Copyright, Trademark

H v. H High Court of Bombay Text of the judgement can be found here The Bombay High Court recently refused to vacate an injunction granted to a country liquor distillery in a trademark and copyright dispute against another distiller for alleged infringement and passing off. In doing so, the court relied on Cadila to examine the similarities between the two labels. The court also observed that the appellate court was merely to examine whether the discretion of the lower

Of Deceptive Similarity, Vacating of Injunctions and Country Liquor Read More »

SpicyIP Tidbit: India 2nd Largest User of PCT Among Developing Countries

/ By / Others, Patent

A press release by WIPO on 13th March, 2014 reveals that 2013 saw new records being broken when more than 200,000 international patent applications were filed in a single year, for the first time. Records were also broken in international trademark and industrial design filings. International Patent Applications are filed under the Patent Cooperation Treaty (PCT). While the USA (with 57,239 applications) and Japan (with 43,918 applications) predictably filed the highest number of patent applications, India has emerged the 2nd

SpicyIP Tidbit: India 2nd Largest User of PCT Among Developing Countries Read More »

Scroll to Top